Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy

被引:8
|
作者
Lee, Mingfeng [1 ]
Suzuki, Hitoshi [1 ]
Kato, Rina [1 ]
Fukao, Yusuke [1 ]
Nakayama, Maiko [1 ]
Kano, Toshiki [1 ]
Makita, Yuko [1 ]
Suzuki, Yusuke [1 ]
机构
[1] Juntendo Univ, Fac Med, Dept Nephrol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan
关键词
IgA nephropathy; Galactose-deficient IgA1; KM55; IgA deposition; GLYCOSYLATION;
D O I
10.1007/s13730-020-00508-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In several cases with IgA nephropathy (IgAN), differential diagnosis is difficult due to the complication with other systemic diseases which can induce secondary IgAN. Recently, we demonstrated that immunostaining with galactose-deficient IgA1-specific monoclonal antibody (KM55 mAb) specifically showed positive in primary IgAN cases. Here, we report four cases which we could make definitive diagnosis by immunohistological analysis using KM55 mAb. The underlying systemic diseases are rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), hepatitis C (HCV) and Crohn's disease (CD). Renal pathological findings in the four cases revealed mesangial proliferative glomerulonephritis with IgA and C3 deposits. Immunostaining with KM55 mAb was positive for three cases complicated with RA, SLE and CD, respectively. Thus, these three cases were diagnosed as primary IgAN and treated with tonsillectomy and steroid pulse therapy. These three cases finally achieved clinical remission. On the other hand, the case with HCV showed negative for KM55. Finally, we diagnosed as HCV-related nephropathy and successfully treated by antiviral agents. These cases suggested KM55 mAb is a strong tool to differentiate primary IgAN from secondary IgAN.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 50 条
  • [31] Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy
    Youxia Liu
    Xiangchun Liu
    Junya Jia
    Jie Zheng
    Tiekun Yan
    Journal of Translational Medicine, 17
  • [32] Diagnostic and prognostic value of galactose-deficient IgA1 in patients with IgA nephropathy: an updated systematic review with meta-analysis
    Zeng, Qin
    Wang, Wen-Ru
    Li, Yi-Han
    Liang, Ying
    Wang, Xin-Hui
    Yan, Lei
    Yu, Ren-Huan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [33] Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy
    Liu, Youxia
    Li, Hongfen
    Yu, Huyan
    Wang, Fanghao
    Jia, Junya
    Yan, Tiekun
    BMC NEPHROLOGY, 2022, 23 (01)
  • [34] Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation
    Kawabe, Mayuko
    Yamamoto, Izumi
    Yamakawa, Takafumi
    Katsumata, Haruki
    Isaka, Nao
    Katsuma, Ai
    Nakada, Yasuyuki
    Kobayashi, Akimitsu
    Koike, Kentaro
    Ueda, Hiroyuki
    Tanno, Yudo
    Koike, Yusuke
    Miki, Jun
    Yamada, Hiroki
    Kimura, Takahiro
    Ohkido, Ichiro
    Tsuboi, Nobuo
    Yamamoto, Hiroyasu
    Kojima, Hiromi
    Yokoo, Takashi
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [35] Porphyromonas gingivalis infection in the oral cavity is associated with elevated galactose-deficient IgA1 and increased nephritis severity in IgA nephropathy
    Seigo Ito
    Taro Misaki
    Yasuyuki Nagasawa
    Ryota Nomura
    Shuhei Naka
    Akiko Fukunaga
    Daiki Matsuoka
    Saaya Matayoshi
    Michiyo Matsumoto-Nakano
    Kazuhiko Nakano
    Clinical and Experimental Nephrology, 2024, 28 : 192 - 200
  • [36] Porphyromonas gingivalis infection in the oral cavity is associated with elevated galactose-deficient IgA1 and increased nephritis severity in IgA nephropathy
    Ito, Seigo
    Misaki, Taro
    Nagasawa, Yasuyuki
    Nomura, Ryota
    Naka, Shuhei
    Fukunaga, Akiko
    Matsuoka, Daiki
    Matayoshi, Saaya
    Matsumoto-Nakano, Michiyo
    Nakano, Kazuhiko
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024, 28 (03) : 192 - 200
  • [37] Humoral immune responses primed by the alteration of gut microbiota were associated with galactose-deficient IgA1 production in IgA nephropathy
    Gao, Li
    Li, Huixian
    Liu, Xiaoling
    Li, Haiyun
    Li, Peiqi
    Lu, Wanhong
    Xie, Xinfang
    Lv, Jicheng
    Jin, Jing
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [38] Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors
    Zachova, Katerina
    Jemelkova, Jana
    Kosztyu, Petr
    Ohyama, Yukako
    Takahashi, Kazuo
    Zadrazil, Josef
    Orsag, Jiri
    Matousovic, Karel
    Galuszkova, Dana
    Petejova, Nadezda
    Mestecky, Jiri
    Raska, Milan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (05): : 908 - 917
  • [39] Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy
    Youxia Liu
    Hongfen Li
    Huyan Yu
    Fanghao Wang
    Junya Jia
    Tiekun Yan
    BMC Nephrology, 23
  • [40] Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion via miR-98-5p in Pediatric IgA Nephropathy
    Liu, Caiqiong
    Li, Xiaoyan
    Shuai, Lanjun
    Dang, Xiqiang
    Peng, Fangrong
    Zhao, Mingyi
    Xiong, Shiqiu
    Liu, Ying
    He, Qingnan
    FRONTIERS IN PHARMACOLOGY, 2021, 12